A Randomized Phase II Study of Reolysin in Patients With Previously Treated Advanced or Metastatic, Non Small Cell Lung Cancer Receiving Standard Salvage Therapy
Phase of Trial: Phase II
Latest Information Update: 03 Apr 2017
At a glance
- Drugs Pelareorep (Primary) ; Docetaxel; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 10 Aug 2016 Additional data of sub group analysis (female patients) published in Oncolytics Biotech media release.
- 07 Jun 2016 Results analyzing efficacy and safety presented at the 52nd Annual Meeting of the American Society of Clinical Oncology.
- 19 May 2016 Interim results from this trial will be presented at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting, according to an Oncolytics Biotech media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History